| 000 | 01285 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511190518.0 | ||
| 264 | 0 | _c19920923 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0020-9996 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarvlin, M J | |
| 245 | 0 | 0 |
_aPhase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent. _h[electronic resource] |
| 260 |
_bInvestigative radiology _cAug 1992 |
||
| 300 |
_aS16-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 |
_aGadolinium _xadministration & dosage |
| 650 | 0 | 4 |
_aHeterocyclic Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDe Simone, D N | |
| 700 | 1 | _aMeeks, M J | |
| 773 | 0 |
_tInvestigative radiology _gvol. 27 Suppl 1 _gp. S16-21 |
|
| 999 |
_c1512631 _d1512631 |
||